>>12701904"The official Full Prescribing Information (also called the ‘label’ or the ‘package insert’) for antidepressants describes multiple adverse effects in the sections on Warnings, Precautions and Adverse Effects. The material in the Warnings and Precautions section is part of the class label for all antidepressants and therefore appears in almost identical language in the Full Prescribing Information section of every antidepressant drug label (see Scientific Sections 6 & 12). The 2014 Lexapro Full Prescribing Information (see Scientific Section 12), for example, states:
All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases.
The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric. p. 6
Note the enormous range of symptoms and disorders caused by antidepressants. Most of the above symptoms are related to and can lead to mania, violence or suicide. That these adverse drug reactions can occur in nonpsychiatric patients confirms that the drug is the culprit and not that patient’s own emotional problems. They are commonly mistaken for the patient’s emotional problems instead of being correctly identified as adverse drug reactions. They can occur in mild or severe forms. Note that the highest risk is around the time of the starting the drug or dose changes, up or down."
